Pharma & Biotech

Unveil the complexity of cellular analysis with DeciBio's market intelligence package. This report bundle includes our industry-leading reports on the Spatial Biology and Single Cell Analysis markets.

Stay ahead of the curve in the rapidly evolving oncology diagnostics landscape with DeciBio's market intelligence package. This bundle combines our industry-leading reports on two key segments: oncology liquid biopsy and clinical oncology biomarker testing.

The second edition of this report provides an overview of the digital pathology market from 2024 to 2029. The digital pathology market, as defined in this report, is comprised of revenue from instruments and software sold to clinical, academic, biopharma, and CRO customers, along with service revenues generated by CROs and reference labs.

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.